mebeverine has been researched along with Liver Steatosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez de Sotomayor, M; Claro, C; Herrera, MD; Parrado, J; Perez-Ternero, C | 1 |
Hirai, H; Kitamura, S; Matsumoto, K; Nakaya, M; Shojo, A | 1 |
2 other study(ies) available for mebeverine and Liver Steatosis
Article | Year |
---|---|
Rice bran enzymatic extract reduces atherosclerotic plaque development and steatosis in high-fat fed ApoE-/- mice.
Topics: Acyl Coenzyme A; Animals; Antioxidants; Aspartate Aminotransferases; Cholesterol, Dietary; Diet, High-Fat; Dietary Fiber; Dietary Supplements; Dose-Response Relationship, Drug; Fatty Liver; Inflammation; Intercellular Adhesion Molecule-1; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylpropionates; Phytosterols; Plant Extracts; Plaque, Atherosclerotic; PPAR alpha; Tocotrienols; Vascular Cell Adhesion Molecule-1 | 2017 |
Hypolipidemic effects of starch and γ-oryzanol from wx/ae double-mutant rice on BALB/c.KOR-Apoe(shl) mice.
Topics: Animals; Apolipoproteins E; Body Weight; Cecum; Diet, High-Fat; Dietary Carbohydrates; Drug Interactions; Eating; Fatty Liver; Feces; Food, Genetically Modified; Gene Expression Regulation; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred BALB C; Mutation; Non-alcoholic Fatty Liver Disease; Oryza; Phenylpropionates; Starch; Sucrose | 2013 |